Comparison of the efficacy and safety of 5% garlic gel and clobetasol propionate ointment in the treatment of alopecia areata: An investigator- blinded randomized controlled trial Emerging Technologies and Therapies

被引:0
|
作者
Bautista, A. F. A.
Ismael, D. K.
Tan, J. B.
Bince, B. P.
机构
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
067
引用
收藏
页码:577 / 577
页数:1
相关论文
共 27 条
  • [21] Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial
    Liang, Surong
    Shang, Shuai
    Zhang, Wensi
    Tan, Ansheng
    Zhou, Boyang
    Mei, Xueling
    Li, Linfeng
    FRONTIERS IN MEDICINE, 2023, 10
  • [22] Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial
    Liu, Lunfei
    Zhang, Chunlei
    Wang, Jinyan
    Chen, Kun
    Ding, Yangfeng
    Yan, Guofu
    Lu, Qianjin
    Li, Wei
    Fang, Hong
    Cheng, Hao
    Zhang, Jianzhong
    He, Yanling
    Zhu, Wei
    Lu, Yan
    Huang, Jinhua
    Pan, Weili
    Li, Ming
    Cao, Shuanglin
    Li, Shanshan
    Han, Xiuping
    He, Li
    Chen, Yayuan
    Zheng, Min
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 580 - 590
  • [23] Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial
    Lunfei Liu
    Chunlei Zhang
    Jinyan Wang
    Kun Chen
    Yangfeng Ding
    Guofu Yan
    Qianjin Lu
    Wei Li
    Hong Fang
    Hao Cheng
    Jianzhong Zhang
    Yanling He
    Wei Zhu
    Yan Lu
    Jinhua Huang
    Weili Pan
    Ming Li
    Shuanglin Cao
    Shanshan Li
    Xiuping Han
    Li He
    Yayuan Chen
    Min Zheng
    European Journal of Dermatology, 2020, 30 : 580 - 590
  • [24] Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor-and analyst-blinded, randomized controlled trial with a short-term follow-up
    Lajevardi, Vahideh
    Ghayoumi, Afsaneh
    Abedini, Robabeh
    Hosseini, Hamed
    Goodarzi, Azadeh
    Akbari, Zahra
    Hedayat, Kosar
    JOURNAL OF COSMETIC DERMATOLOGY, 2017, 16 (02) : 235 - 242
  • [25] Comparison of the efficacy and safety of a 730-nm picosecond titanium sapphire laser and a 1064-nm picosecond neodymium yttrium aluminum garnet laser for the treatment of acquired bilateral nevus of Ota-like macules: A split-face, evaluator-blinded, randomized, and controlled pilot trial
    Chen, Wanxin
    Wang, Zhongshuai
    Li, Zhenzhen
    Yuan, Chen
    Zhang, Xiaofeng
    Li, Li
    Yan, Yan
    Wang, Baoxi
    JOURNAL OF COSMETIC DERMATOLOGY, 2024, 23 (12) : 3961 - 3967
  • [26] Comparison of the efficacy and safety between a low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser and a conventional Q-switched 532-nm laser for the treatment of cafe-au-lait macules in 40 Chinese children: a prospective, randomized, parallel-controlled, evaluator-blinded trial
    Yin Zhuang
    Minghuan Huang
    Jinwen Shen
    Lei Wang
    Liping Yang
    Aifang Jiang
    Zhirong Yao
    Xia Yu
    Lasers in Medical Science, 2022, 37 : 279 - 286
  • [27] Comparison of the efficacy and safety between a low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser and a conventional Q-switched 532-nm laser for the treatment of cafe-au-lait macules in 40 Chinese children: a prospective, randomized, parallel-controlled, evaluator-blinded trial
    Zhuang, Yin
    Huang, Minghuan
    Shen, Jinwen
    Wang, Lei
    Yang, Liping
    Jiang, Aifang
    Yao, Zhirong
    Yu, Xia
    LASERS IN MEDICAL SCIENCE, 2022, 37 (01) : 279 - 286